Literature DB >> 34741231

Acquired night blindness due to rod dysfunction after long-term hemodialysis.

Shinji Ueno1, Satoshi Okado2.   

Abstract

PURPOSE: To report the clinical findings in 6 patients who developed night blindness after long-term hemodialysis. STUDY
DESIGN: Retrospective case series. PATIENTS AND METHODS: The medical charts of the 6 patients were examined. The fundus photographs, spectral-domain optical coherence tomographic (SD-OCT) images, full-field ERGs, and blood chemistry panels were analyzed.
RESULTS: The mean age of the 6 patients (4 men) at the time of diagnosis was 69.1 ± 5.9 years. The mean duration of the hemodialysis was 21.8 ± 13.4 years (7-41 years). The visual acuity of the patients was preserved at 20/30 or better except in 1 eye. Ophthalmoscopy showed white flecks that were scattered over the midperipheral retina in all the eyes. SD-OCT showed mild macular degeneration in 5 eyes. The scotopic ERGs elicited by dim flashes were absent, and those elicited by bright flashes had negative waveforms. The photopic ERGs were relatively well preserved. These data indicated a rod-specific dysfunction that may account for the night blindness. The plasma concentration of vitamin A was within the normal range in 4 of the patients and slightly lower than the normal limit in 1 of the patients. Administration of vitamin A was performed for 1 patient, and the symptom of night blindness and scotopic ERGs were improved 3 months later. DISCUSSION: Long-term hemodialysis can be associated with the night blindness that may be caused by vitamin A deficiency, even though the plasma concentration of vitamin A in these patients was within the normal range.
© 2021. Japanese Ophthalmological Society.

Entities:  

Keywords:  ERGs; Hemodialysis; Night blindness; Rod dysfunction; Vitamin A deficiency

Mesh:

Year:  2021        PMID: 34741231     DOI: 10.1007/s10384-021-00883-z

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  2 in total

1.  Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy.

Authors:  A H Milam; J C Saari; S G Jacobson; W P Lubinski; L G Feun; K R Alexander
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-01       Impact factor: 4.799

2.  RPE65 mutation frequency and phenotypic variation according to exome sequencing in a tertiary centre for genetic eye diseases in China.

Authors:  Shiqiang Li; Xueshan Xiao; Zhen Yi; Wenmin Sun; Panfeng Wang; Qingjiong Zhang
Journal:  Acta Ophthalmol       Date:  2019-07-05       Impact factor: 3.761

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.